Apixio Payment Integrity

Apixio Payment Integrity

Apixio Payment Integrity/The Rawlings Company LLC/Varis LLC operates as a coordinated investment and services platform targeting payment integrity and cost containment in the US healthcare system. The group focuses on identifying improper payments across Medicare Advantage, commercial, and Medicaid managed-care plans. Its economics are tied directly to recoveries rather than management fees, creating a performance-contingent revenue profile. Active investment is concentrated in healthcare payment integrity, a niche that combines claims auditing, data science, and legal recovery. Asset classes include litigation finance, specialty finance, and revenue-cycle management equity. The platform covers the full lifecycle from identification through pursuit — transaction sizes typically vary by recovery complexity. Operations span the United States, with activity concentrated in major payer markets including New York, Florida, Texas, and California. Deployment flows into funding audits, carrying the cost of litigation, and occasionally acquiring distressed provider claims portfolios. The platform's scale and headcount are not publicly disclosed, operating through a distributed but integrated model with the Rawlings Company historically based in Kentucky. A dated operational highlight: in December 2023, Apixio was reportedly integrating its AI audit suite with Rawlings' recovery arm to accelerate subrogation timelines. No adjacent philanthropic vehicles or club memberships are publicly associated with the group. This structure separates it from standard private equity healthcare roll-ups. Rather than buying companies to improve operations, the tri-party arrangement fuses a technology company, a law firm-adjacent recovery business, and a funding vehicle into a single economic alignment. Governance and succession details remain opaque, but the operating logic — technology identifies the value, operations extract it, capital underwrites the process — functions as a closed-loop investment thesis.